My 2019 schedule
In 2019, I will be speaking at the following meetings. If you are a Member of Simple and Practical Mental Health and will be at any of these meetings, I would love to meet you!
(My speaking engagements will be added on this page as they are confirmed.)
April 26 and 27, 2019
NEI Synapse, Asheville, North Carolina
April 28 to May 1, 2019
MasterPsych Child & Adolescent Psychiatry Conference, Isle of Palms, SC
October 3 to 6, 2019
MasterPsych Psychiatry Conference, La Jolla, California
My 2018 schedule
In 2018, I spoke at the following meetings. It was nice meeting several Members of Simple and Practical Mental Health at these meetings.
Sunday, March 25, 2018
American Society for Clinical Psychopharmacology’s Spring meeting Psychopharmacology Update: State-of-the-Art 2018, University of California, Los Angeles (UCLA) Luskin Center, Los Angeles, California.
Monday, May 7, 2018
Annual meeting of the American Psychiatric Association, New York, New York.
Wednesday, May 30, 2018
Keynote speaker. 6th Annual Psychiatry Symposium: Update on Depressive Disorders, Jersey Shore University Medical Center, Neptune, New Jersey.
Thursday, May 31, 2018
American Society for Clinical Psychopharmacology’s annual meeting. Miami Beach, Florida.
Sunday, October 14, 2018
MASTERPSYCH 2018 Live Conference, Santa Barbara, California.
Friday, November 2, 2018
Southern California Kaiser Permanente Symposium, California.
November 7 – 11, 2018
NEI Congress, Orlando, Florida
Below are some topics on which I have done talks at different institutions. These talks have been highly acclaimed as being very clear and clinically useful. To invite me to give one of these talks at your institution or to request a talk on a different topic, email me at rajnishmago@gmail.com.
Note: These talks are not necessarily listed in the order of importance or my preference.
Pharmacogenomic testing: What’s reality versus fantasy at the cutting edge of psychopharmacology
Practical Management of Common Side Effects of Psychotropic Medications
(Covers sexual dysfunction,excessive sweating, nausea, dry mouth, orthostatic hypotension, etc)
Pharmacogenomic Testing to Predict and Reduce Side Effects of Psychotropic Medications.
Medically Serious Adverse Effects of Antidepressant Medications
(Covers bleeding, hyponatremia, seizures, QT prolongation, etc)
Stop the Roller Coaster: Managing Treatment-Resistant Bipolar Disorder
Common Medical Conditions that Present with Psychiatric Symptoms but are Commonly Missed by Us
(This covers Sleep Apnea, Polycystic Ovarian Syndrome, and Others)
A Primer on the Various Thyroid and Liver Function Tests for the Mental Health Clinician
Overview of Non-stimulant Pharmacotherapy of ADHD
(This covers atomoxetine, guanfacine, clonidine, bupropion, modafinil, TCAs, etc)
Using Rating Scales to Enhance Clinical Practice
Evaluation and Management of Antidepressant-Induced Sexual Dysfunction
A Practical Guide to Clinically-Important Drug Interactions
Clinicians’ Guide to Reading and Applying Clinical Trial Results
(A simple guide for those without a research background who want to be able to empowered to understand the basics when they come across a clinical trial.)
Psychopharmacology of Mood Disorders in Women
The Internet as a Tool in Clinical Practice
(A series of websites are amazingly useful yet unknown to most clinicians. This talk is simple but extremely useful for clinicians and – trust me–has been very much appreciated by the audience.)
Adult ADHD: Diagnosis and Assessment
The Latest Antidepressants: A Review for Clinicians
Cardiovascular Adverse Effects of Newer Antidepressants
(excluding TCAs and MAOIs)
Adult ADHD: Pages from Clinical Experience
(Especially suited for an audience that is not yet convinced that it is extremely important that we diagnose and treat ADHD. Includes case vignettes and covers key principles of assessment.)
Different Sources of Evidence: When, Where, and How
(Covers when and how to find and use practice guidelines vs. systematic reviews/ meta-analyses vs. clinical trials.)
Adverse effects of mood stabilizers and their effect on nonadherence
Leave a Reply: